Lilly 1Q Revenues: $7.0 billion (-11%)  1Q Earnings: $1.3 billion (-29%)  Comments: Decline in revenues was driven by a 5% decrease due to lower realized prices, a 4% decrease due to lower volume, and a 2% decrease from the unfavorable impact of foreign exchange rates. The decline was driven by $1.47 billion in revenue from COVID-19 antibodies in 1Q22, with sales in the quarter down 100%. New Products contributed $573.6 million to revenue in the quarter. Growth Products revenue increased 18% ...